Friday, May 22, 2026

Something’s tightening under my skin’ by Dr.Lata Bichile, a rheumatologist at Centre for Arthritic and Rheumatic Diseases Treatment in Mumbai.

MK, a 42-year-old engineer, walked into my OPD along with his wife in August 2023. He had been experiencing swelling and stiffness in his right forearm for the past 4 months with a shooting pain from the wrist to the fingers, making simple movements like bending his fingers, bending his elbow or turning his wrist difficult. Similar pain and stiffness had begun appearing in both thighs and his left upper arm as well. So much so that he struggles to sit down and stand up. Even lifting his left arm hurt. “ it feels as if something inside is tightening:, he said.


MK had no fever, no weight loss, no breathlessness, no cough, no colour changes in his fingers and no known allergies or asthma. His hands and feet were normal. That detail stood out. In some autoimmune diseases, the skin on the fingers thickens or changes colour. But here, the extremities were entirely spread- a clue that steered my mind towards a much rarer possibility.


On examination, his right elbow movement was restricted. The skin over his forearm and thighs appeared subtly puckered- almost tethered down. His median nerve seemed affected, causing numbness in his fingers. Yet, his muscle strength was normal, reflexes intact, and the other organ system perfectly fine.
Could this be Eosinophilic Fasciitis? I wondered.


Eosinophilic Fasciitis, or Shulman syndrome, is a rare inflammatory condition affecting the fascia- the thin layer of connective tissue that surrounds our muscles. It causes painful swelling, tightness, and skin thickening. Only a few 100 cases have been reported worldwide since it was 1st described in 1974. Most patients are middle aged, though it can occur at almost any age. Many doctors may never encounter it in their career.


His blood tests revealed high inflammation markers (ESR, CRP) and very high eosinophils- a type of white blood cells that can indicate inflammation. His muscle enzyme levels were normal, helping rule out primary muscle disease. Tests for autoimmune diseases- ANA, Anti-Scl70, Anti-centromere, ANCA- were negative, which helped exclude systemic sclerosis and other mimicking disorders.


He was not willing to undergo a biopsy as it was an invasive procedure. So, I ordered an MRI of his thighs. Imaging today often helps confirm what we suspect clinically. The scan showed exactly what I had thought= inflammation and fluid along the fascial layers, with thickening but no muscle damage- a textbook picture of Eosinophilic Fasciitis.


I explained to him and his wife that this was a rare but treatable condition, and that we had caught it early. Relief flooded their faces. People with rare illnesses often fear they are being dismissed or misunderstood. We started treatment with high-dose steroids, carefully adjusted to his body weight and monitored. 

Alongside, we gave him a steroid-sparing medication to protect him long-term. Physiotherapy became an important part of recovery. I scheduled close follow-ups as rare diseases deserve regular attention.
3 months later, he returned smiling. His elbow moved normally, his thighs were supple, his shoulder pain had disappeared, and the skin tightening had eased dramatically. He continued working without interruption. His consistency, trust, and calm courage played a big role in his improvement.


I am 75 and, in a career spanning around 35 years, I’ve seen only 2 cases of Eosinophilic Fasciitis. But every rare patient reinforces key lessons: awareness, early diagnosis, and trust in treatment matters. This peculiar case shows how rare diseases may masquerade as routine problems. The case also taught me that not every success in medicine is dramatic. Sometimes, victory looks like a restored elbow bend, a pain-free walk or a man returning to work feeling whole again.



This is only for your information, kindly take the advice of your doctor for food, medicines, exercises and so on.   


Labels: , , , , , , , , , ,

Saturday, January 03, 2026

physician warns ‘never ignore vitamin B12 deficiency’; shares how it can lead to serious long term health issues

 Vitamin B12 is vital for energy and brain function. Dr Chetan Kothari warns that neglecting signs of deficiency can lead to serious health problems.

Many of us don’t pay attention to vitamin B12, but it’s a powerhouse nutrient your body needs for energy, brain function, and overall health. Ignoring it can cause tiredness, brain fog, nerve issues, and more. Dr Chetan Kothari, a general physician based in Indore with 25+ years of experience, shares in his January 1 Instagram post how ignoring B12 deficiency can have long-term consequences and explains how it impacts overall well-being. 

Common signs of vitamin B12 deficiency

“I’m going to talk to you today about vitamin B 12 deficiency and how it can cause certain symptoms,” Dr Kothari said. He explained, “It can lead to numbness or tingling in the body, and sometimes, even while driving, you might suddenly feel dizzy. These may seem like minor issues, but they shouldn’t be ignored.”

The doctor stressed that even small signs need attention. “Sudden bouts of dizziness or other mild symptoms shouldn’t be overlooked. If any of these signs appear, a B12 level test should be done as soon as possible. The good news is that it can be detected with a simple blood test, and the treatment is straightforward. Something so small can cause major issues if left unchecked.”

How can timely intervention help

Dr Kothari added that timely intervention not only helps prevent serious health complications but also ensures better energy levels, improved brain function, and overall well-being. He encouraged people to be proactive about their B12 levels and consult a doctor if they notice any unusual symptoms.

 

 

This is only for your information, kindly take the advice of your doctor for medicines, exercises and so on.   

Labels: , , , , , , , , ,

Saturday, December 27, 2025

New blood test can predict risk of heart disease

A team of scientists from Harvard and Oxford universities is developing a simple blood test to predict the risk of complications from hypertrophic cardiomyopathy (HCM), the most common inherited heart condition. The disease, which affects millions globally, is caused by genetic changes and usually runs in families. While some people with HCM experience no symptoms or mild ones, others may face severe complications like heart failure or cardiac arrest. 

 Blood test could identify high-risk patients

The blood test, which measures levels of a protein called N-terminal Pro-B-type natriuretic peptide (NT-Pro-BNP), could help identify patients at high risk of complications. This would allow for closer monitoring or life-saving treatment. The study involved measuring NT-Pro-BNP levels in the blood of 700 HCM patients and found that those with higher levels had poorer blood flow and more heart changes that could lead to atrial fibrillation or heart failure. 

Test could revolutionize care for HCM patients

The blood test has the potential to transform care for millions of people with HCM. Study leader Prof Carolyn Ho from Harvard Medical School said, "Continued studies on blood biomarkers will lead to better understanding of HCM so that, in future, we can offer our patients a blood test to identify who is at high versus low risk." She added this could help target life-saving treatments effectively and avoid unnecessary ones for low-risk patients. 

Personal stories highlight need for risk assessment

Lara Johnson, a 34-year-old from Southampton, UK, who was diagnosed with HCM eight years ago, said a simple blood test could help identify future risks earlier. "It could give people like me a chance to prepare and adjust our lifestyles as needed," she said. "That kind of clarity wouldn't only help me, it would make a world of difference for my whole family." 

Test could benefit patients worldwide

Prof Bryan Williams, Chief Scientific and Medical Officer of the British Heart Foundation which funded the research, said the test "could benefit patients around the world." He added that measuring different proteins in blood could help predict heart function and future risk of complications from heart disease. This new method may also provide insights into how HCM affects heart structure and function, potentially leading to new treatment strategies.

 

 

This is only for your information, kindly take the advice of your doctor for medicines, exercises and so on.   

 


Labels: , , ,